Senior insider sale
EVP & CFO at ROYALTY PHARMA PLC — senior position signals high conviction
$10.09M
203.56K shares
COYNE TERRANCE P. plans to sell 203.56K shares of ROYALTY PHARMA PLC valued at approximately $10.09M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Acquired as compensation -- Performance Awards
Compensation
Acquired as compensation -- Performance Awards
Compensation
Acquired as compensation -- Performance Awards
Compensation
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/6/2026 | Acquired as compensation -- Performance Awards Compensation | 24.26K | — |
2/11/2026 | Acquired as compensation -- Performance Awards Compensation | 26.63K | — |
5/8/2025 | Acquired as compensation -- Performance Awards Compensation | 13.51K | — |
| Total | 64.40K | ||
Completed
Units to sell
32.92K
Market value
$1.64M
Units to sell
1.88K
Market value
$93.3K
Units to sell
32.92K
Market value
$1.59M
Units to sell
1.88K
Market value
$90.6K
Units to sell
32.92K
Market value
$1.50M
Units to sell
1.88K
Market value
$85.4K
Units to sell
1.88K
Market value
$87.7K
Units to sell
32.92K
Market value
$1.54M
Planned — Approximate Date
Units to sell
64.40K
Market value
$3.47M
Units
203.56K
Value
$10.09M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/28/2026 | 32.92K | $1.64M | — | Completed |
4/28/2026 | 1.88K | $93.3K | — | Completed |
4/1/2026 | 32.92K | $1.59M | — | Completed |
4/1/2026 | 1.88K | $90.6K | — | Completed |
3/23/2026 | 32.92K | $1.50M | — | Completed |
3/23/2026 | 1.88K | $85.4K | — | Completed |
3/2/2026 | 1.88K | $87.7K | — | Completed |
3/2/2026 | 32.92K | $1.54M | — | Completed |
| Planned — Approximate Date | ||||
5/26/2026 | 64.40K | $3.47M | NASD | Planned |
| Total | 203.56K | $10.09M | ||